BioSpace News Archive

ILiAD Biotechnologies, LLC (ILiAD) presented a breakthrough finding today on the effect of BPZE1, a live attenuated intranasal pertussis vaccine, on serum bactericidal activity (SBA) against PRN(+) and PRN(-) Bordetella pertussis strains at the virtual ID Week 2021 conference (sponsored by Infectious Disease Society of America).

Celldex Therapeutics, Inc. announced positive data on measurements of symptom control and quality of life from the Company’s ongoing, open label Phase 1b clinical trial of CDX-0159 in patients with antihistamine refractory cold urticaria and symptomatic dermographism, the two most common forms of chronic inducible urticaria.

Natera, Inc. (NASDAQ: NTRA), is pleased that the Delaware Federal District Court ruled today that all three patents CareDx has asserted against Natera “are invalid as a matter of law under §101 for claiming patent-ineligible subject matter.”

Geneva, Switzerland, September 29, 2021 - Addex Therapeutics, a clinical-stage pharmaceutical company pioneering allosteric modulation-based drug discovery and development, announced that CEO, Tim Dyer, will present at the Cantor Global Healthcare 2021 Conference.

Biophytis SA announces it will present full results from the SARA-INT Phase 2 trial of Sarconeos in Sarcopenia at the International Congress on Frailty and Sarcopenia Research to be held virtually from September 29 to October 02, 2021.

Avacta Group plc is pleased to announce that a pre-clinical development milestone has been achieved in the multi-target therapeutics development partnership with LG Chem Life Sciences, the life sciences division of the South Korean LG Group, triggering an undisclosed milestone payment.

Atara Biotherapeutics, Inc., announced the upcoming full release of new translational data and two-year open-label extension clinical data from the study of ATA188 in progressive multiple sclerosis.

The demand within the hospital outsourcing market is slated to rise alongside advancements in medical care and diagnostics.

The demand within the global healthcare provider network management market is set to increase at a sturdy rate in the times to follow.

In last few years, there has been a notable rise in digital healthcare. It is based on an intersection of genomic & digital technology with healthcare and society.